Johnson & Johnson (JNJ) Dividends Paid - Common (2009 - 2026)
Johnson & Johnson (JNJ) posted Dividends Paid - Common of $3.2 billion for Q2 2026, up 3.07% sequentially from $3.1 billion in Q1 2026, and up 3.13% YoY from $3.1 billion in Q2 2025.
Johnson & Johnson (JNJ) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Johnson & Johnson has reported Dividends Paid - Common for 18 years, with the latest figure at $3.2 billion in Q2 2026.
- Quarterly Dividends Paid - Common rose 3.13% year-over-year to $3.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.6 billion (up 4.42% YoY) and the FY2025 annual result came in at $12.4 billion, up 4.72% from the prior year.
- Dividends Paid - Common rose to $3.2 billion in Q2 2026 per JNJ's latest filing, from $3.1 billion in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $3.4 billion in Q1 2023 and troughed at $2.8 billion in Q2 2022.
- A 5-year average of $3.0 billion and a median of $3.0 billion in 2024 frame the typical range for Dividends Paid - Common.
- The widest YoY moves for Dividends Paid - Common: up 5.56% in 2023, down 16.74% in 2023.
- Over 5 years, Dividends Paid - Common stood at $2.8 billion in 2022, then grew by 2.8% to $2.9 billion in 2023, then climbed by 4.15% to $3.0 billion in 2024, then advanced by 4.93% to $3.1 billion in 2025, then advanced by 3.07% to $3.2 billion in 2026.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered $3.2 billion, $3.1 billion, and $3.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 2.87 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 6.58 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.03 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 2.45 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 3.23 Bn |
| Jun 28, 2026 | 3.23 Bn |
| Mar 29, 2026 | 3.13 Bn |
| Mar 29, 2026 | 3.13 Bn |
| Dec 28, 2025 | 3.13 Bn |
| Dec 28, 2025 | 3.13 Bn |
| Sep 28, 2025 | 3.13 Bn |
| Sep 28, 2025 | 3.13 Bn |
| Jun 29, 2025 | 3.13 Bn |
| Jun 29, 2025 | 3.13 Bn |
| Mar 30, 2025 | 2.99 Bn |
| Mar 30, 2025 | 2.99 Bn |
| Dec 29, 2024 | 2.98 Bn |
| Dec 29, 2024 | 2.98 Bn |
| Sep 29, 2024 | 2.99 Bn |
| Sep 29, 2024 | 2.99 Bn |
| Jun 30, 2024 | 2.99 Bn |
| Jun 30, 2024 | 2.99 Bn |
| Mar 31, 2024 | 2.87 Bn |
| Mar 31, 2024 | 2.87 Bn |